Investigator
James O'donnell
WASHINGTON UNIVERSITY · funded by NHLBI
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $653k
- First award
- May 15, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- ENDEAVOR HEALTH CLINICAL OPERATIONS100momentum
OncologyPhase III
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- P01
Role of glycans in VWF biology and VWD pathogenesis
$338kMay 15, 2025NHLBIWASHINGTON UNIVERSITYNIH RePORTER · 11016813 (opens the source filing in a new tab)
- P01
Role of glycans in VWF biology and VWD pathogenesis
$316kMay 15, 2025NHLBIWASHINGTON UNIVERSITYNIH RePORTER · 11327279 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources